---
schema_version: "secwatch.filing_event.v1"
accession: "0001365916-23-000151"
form_type: "8-K"
ticker: null
cik: "0001365916"
company_name: "AMYRIS, INC."
filed_at: "2023-12-29T23:59:59+00:00"
generated_at: "2026-06-07T05:46:41.912347+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Amyris sells Biossance brand for $20M, cuts 220 jobs; Nov net loss $36.7M

## Summary
- Sold Biossance brand assets to THG Beauty USA LLC for $20M; Bankruptcy Court approved Dec 12, closed Dec 28.
- Terminated approx 220 employees Dec-Jan 2024; combined RIFs reduce workforce ~51% from June 2023.
- Expects $2.4M one-time charge in Q4 2023/Q1 2024 for severance and benefits.
- Nov 2023 MOR: net loss $36.7M, cumulative net loss $167.4M, cash $17.6M, total liabilities $1.30B.
- Prepetition unsecured debt $738.7M, equity deficit $489.3M; postpetition payables $175.9M.

## SEC filing metadata
- accession: 0001365916-23-000151
- form_type: 8-K
- cik: 0001365916
- company_name: AMYRIS, INC.
- filed_at: 2023-12-29T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.01, 2.05, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1365916/000136591623000151/0001365916-23-000151-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1365916/000136591623000151/amrs-20231228.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001365916-23-000151
- JSON: https://secwatch.observer/filing/0001365916-23-000151.json
- Plain text: https://secwatch.observer/filing/0001365916-23-000151.txt

## Key facts
- M&A Transactions
  AMYRIS, INC. completed a disposition involving THG Beauty USA LLC for $20 million (closed 2023-12-28).
  - Action: disposition
  - Counterparty: THG Beauty USA LLC
  - Consideration: $20 million
  - Closing: 2023-12-28
  source text: On December 28, 2023, Amyris, Inc. (the “Company”) and THG Beauty USA LLC (“THG”) signed and closed an Asset Purchase Agreement (the “APA”) pursuant to which the Company agreed to sell substantially all of the assets of the Company's clean beauty brand, Biossance ® , to THG for $20 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1365916/000136591623000151/0001365916-23-000151-index.htm
- Material Agreements
  AMYRIS, INC. entered into Asset Purchase Agreement with THG Beauty USA LLC valued at $20 million (effective 2023-12-28).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: THG Beauty USA LLC
  - Value: $20 million
  - Effective: 2023-12-28
  source text: On December 28, 2023, Amyris, Inc. (the “Company”) and THG Beauty USA LLC (“THG”) signed and closed an Asset Purchase Agreement (the “APA”) pursuant to which the Company agreed to sell substantially all of the assets of the Company's clean beauty brand, Biossance ® , to THG for $20 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1365916/000136591623000151/0001365916-23-000151-index.htm
- Restructurings & Charges
  AMYRIS, INC. announced a restructuring with charges of approximately $2.4 million affecting certain consumer brands (approximately 220 employees).
  - Type: restructuring
  - Charge: approximately $2.4 million
  - Affected area: certain consumer brands
  - Headcount: approximately 220 employees
  source text: In connection with the sale of certain consumer brands, the Company announced the termination or separation of approximately 220 employees at different dates beginning on December 18, 2023 and continuing through January 2024. The Company previously announced reductions in force in June 2023 and August 2023, which, together with general attrition, is expected to result in reduction in force of approximately 51% from June 2023 to the end of January 2024. In connection with this reduction in force, certain impacted employees will be provided severance benefits, including cash severance payments and reimbursement of medical insurance premiums. In connection with the December 2023 and January 2024 reduction in force, the Company expects to record a one-time charge of approximately $2.4 million related to the reduction in its workforce, consisting primarily of one-time severance payments upon termination of the employees.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1365916/000136591623000151/0001365916-23-000151-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.